• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

耐碳青霉烯类肺炎克雷伯菌定植患者中发生耐碳青霉烯类肺炎克雷伯菌临床感染的危险因素。

Risk factors for developing clinical infection with carbapenem-resistant Klebsiella pneumoniae in hospital patients initially only colonized with carbapenem-resistant K pneumoniae.

机构信息

Infection Control and Hospital Epidemiology Unit, Soroka University Medical Center and Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

出版信息

Am J Infect Control. 2012 Jun;40(5):421-5. doi: 10.1016/j.ajic.2011.05.022. Epub 2011 Sep 9.

DOI:10.1016/j.ajic.2011.05.022
PMID:21906844
Abstract

BACKGROUND

This study examined predictors of carbapenem-resistant Klebsiella pneumoniae (CRKP) colonization and risk factors for the development of CRKP infection in patients initially only colonized with CRKP.

METHODS

A total of 464 patients with CRKP rectal colonization (CRKP-RC) were identified. Two case-control studies were performed, one comparing risk factors for CRKP-RC in patients who did not develop CRKP infection (CRKP-IN) versus patients without CRKP-RC and CRKP-IN, and the other comparing CRKP-RC patients who did not develop CRKP-IN with those who did.

RESULTS

Forty-two of the 464 colonized patients developed CRKP-IN. Multivariate analysis identified the following predictors for CRKP-RC: antibiotic therapy (odds ratio [OR], 5.76; P ≤ .0001), aminopenicillin therapy (OR, 7.753; P = .004), bedridden (OR, 3.09; P = .021), and nursing home residency (OR, 3.09; P = .013). Risk factors for CRKP-IN in initially CRKP-RC-positive patients were previous invasive procedure (OR, 5.737; P = .021), diabetes mellitus (OR, 4.362; P = .017), solid tumor (OR, 3.422; P = .025), tracheostomy (OR, 4.978; P = .042), urinary catheter insertion (OR, 4.696; P = .037), and antipseudomonal penicillin (OR, 23.09; P ≤ .0001).

CONCLUSIONS

We suggest that in patients with CRKP-RC, a strategy for preventing CRKP-IN might include limiting antipseudomonal penicillin and carbapenem use and preventing infections by closely following compliance with infection control bundles.

摘要

背景

本研究旨在探讨耐碳青霉烯类肺炎克雷伯菌(CRKP)定植的预测因素,以及最初仅定植 CRKP 的患者发生 CRKP 感染的危险因素。

方法

共确定了 464 例 CRKP 直肠定植(CRKP-RC)患者。进行了两项病例对照研究,一项比较了未发生 CRKP 感染(CRKP-IN)的患者与无 CRKP-RC 和 CRKP-IN 的患者发生 CRKP-RC 的危险因素,另一项比较了未发生 CRKP-IN 的 CRKP-RC 患者与发生 CRKP-IN 的患者的危险因素。

结果

464 例定植患者中有 42 例发生了 CRKP-IN。多变量分析确定了 CRKP-RC 的以下预测因素:抗生素治疗(优势比[OR],5.76;P≤0.0001)、氨青霉素治疗(OR,7.753;P=0.004)、卧床不起(OR,3.09;P=0.021)和疗养院居住(OR,3.09;P=0.013)。最初 CRKP-RC 阳性患者发生 CRKP-IN 的危险因素为既往侵入性操作(OR,5.737;P=0.021)、糖尿病(OR,4.362;P=0.017)、实体瘤(OR,3.422;P=0.025)、气管切开术(OR,4.978;P=0.042)、导尿(OR,4.696;P=0.037)和抗假单胞菌青霉素(OR,23.09;P≤0.0001)。

结论

我们建议,对于 CRKP-RC 患者,预防 CRKP-IN 的策略可能包括限制使用抗假单胞菌青霉素和碳青霉烯类药物,并通过密切关注感染控制包的遵守情况来预防感染。

相似文献

1
Risk factors for developing clinical infection with carbapenem-resistant Klebsiella pneumoniae in hospital patients initially only colonized with carbapenem-resistant K pneumoniae.耐碳青霉烯类肺炎克雷伯菌定植患者中发生耐碳青霉烯类肺炎克雷伯菌临床感染的危险因素。
Am J Infect Control. 2012 Jun;40(5):421-5. doi: 10.1016/j.ajic.2011.05.022. Epub 2011 Sep 9.
2
Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case control study.耐碳青霉烯类肺炎克雷伯菌感染的危险因素:一项配对病例对照研究。
J Antimicrob Chemother. 2007 Nov;60(5):1124-30. doi: 10.1093/jac/dkm356. Epub 2007 Sep 20.
3
Impact of carbapenem resistance on the outcome of patients' hospital-acquired bacteraemia caused by Klebsiella pneumoniae.碳青霉烯类耐药对肺炎克雷伯菌引起的医院获得性菌血症患者结局的影响。
J Hosp Infect. 2013 Apr;83(4):307-13. doi: 10.1016/j.jhin.2012.10.012. Epub 2013 Jan 10.
4
Carbapenem-resistant Klebsiella pneumoniae in post-acute-care facilities in Israel.以色列急性后期护理机构中耐碳青霉烯类肺炎克雷伯菌。
Infect Control Hosp Epidemiol. 2011 Sep;32(9):845-53. doi: 10.1086/661279.
5
Carriage rate of carbapenem-resistant Klebsiella pneumoniae in hospitalised patients during a national outbreak.住院患者在全国性爆发期间耐碳青霉烯类肺炎克雷伯菌的携带率。
J Hosp Infect. 2010 Apr;74(4):344-9. doi: 10.1016/j.jhin.2009.07.022. Epub 2009 Sep 26.
6
Risk factors for the acquisition of nosocomial infection with carbapenem-resistant Klebsiella pneumoniae.耐碳青霉烯类肺炎克雷伯菌医院感染的危险因素
South Med J. 2011 Feb;104(2):106-10. doi: 10.1097/SMJ.0b013e318206063d.
7
Impact of carbapenem resistance on epidemiology and outcomes of nonbacteremic Klebsiella pneumoniae infections.碳青霉烯类耐药性对非菌血症性肺炎克雷伯菌感染的流行病学及结局的影响。
Am J Infect Control. 2015 Oct 1;43(10):1076-80. doi: 10.1016/j.ajic.2015.06.008. Epub 2015 Jul 17.
8
Carbapenem-resistant Klebsiella pneumoniae is associated with poor outcome in hemodialysis patients.耐碳青霉烯类肺炎克雷伯菌与血液透析患者预后不良相关。
J Infect. 2012 Oct;65(4):318-25. doi: 10.1016/j.jinf.2012.06.005. Epub 2012 Jun 18.
9
A retrospective study of risk factors for carbapenem-resistant Klebsiella pneumoniae acquisition among ICU patients.一项关于重症监护病房(ICU)患者获得耐碳青霉烯类肺炎克雷伯菌的危险因素的回顾性研究。
J Infect Dev Ctries. 2016 Mar 31;10(3):208-13. doi: 10.3855/jidc.6697.
10
Risk factors for carbapenem-resistant Klebsiella pneumoniae infection/colonization and predictors of mortality: a retrospective study.耐碳青霉烯类肺炎克雷伯菌感染/定植的危险因素及死亡率预测因素:一项回顾性研究。
Pathog Glob Health. 2015 Mar;109(2):68-74. doi: 10.1179/2047773215Y.0000000004. Epub 2015 Feb 24.

引用本文的文献

1
Hypervirulent Carbapenem-resistant Infection: Epidemiology, Virulence, Resistance, and Treatment.高毒力碳青霉烯耐药感染:流行病学、毒力、耐药性及治疗
Infect Drug Resist. 2025 Sep 4;18:4689-4697. doi: 10.2147/IDR.S534490. eCollection 2025.
2
Evaluating the Clinical Benefit of Carbapenem-Resistant Screening in a Tertiary Care Center in Saudi Arabia.评估沙特阿拉伯一家三级医疗中心碳青霉烯类耐药筛查的临床益处。
Infect Drug Resist. 2025 May 26;18:2679-2686. doi: 10.2147/IDR.S518397. eCollection 2025.
3
Experience in Implementing Colonization Screening in a Multidisciplinary County Clinical Hospital in Romania.
罗马尼亚一家多学科县级临床医院实施结肠癌筛查的经验。
Microorganisms. 2025 Mar 28;13(4):775. doi: 10.3390/microorganisms13040775.
4
Plasmid-Mediated Colistin and Fosfomycin Resistance among Clinical Isolates of ESBL- and Carbapenemase-Producing in Northern Iran.伊朗北部产超广谱β-内酰胺酶(ESBL)和碳青霉烯酶临床分离株中质粒介导的黏菌素和磷霉素耐药性
Arch Razi Inst. 2024 Aug 1;79(4):881-888. doi: 10.32592/ARI.2024.79.4.881. eCollection 2024 Aug.
5
Carbapenem-resistant Enterobacterales (CRE) colonisation as a predictor for subsequent CRE infection: A retrospective surveillance study.耐碳青霉烯类肠杆菌科细菌(CRE)定植作为后续CRE感染的预测指标:一项回顾性监测研究。
S Afr J Infect Dis. 2025 Jan 28;40(1):687. doi: 10.4102/sajid.v40i1.687. eCollection 2025.
6
Urinary Tract Infections with Carbapenem-Resistant in a Urology Clinic-A Case-Control Study.泌尿外科门诊耐碳青霉烯类抗生素的尿路感染——一项病例对照研究
Antibiotics (Basel). 2024 Jun 24;13(7):583. doi: 10.3390/antibiotics13070583.
7
Risk factors of Carbapenem-resistant Enterobacterales intestinal colonization for subsequent infections in hematological patients: a retrospective case-control study.血液科患者碳青霉烯类耐药肠杆菌科细菌肠道定植继发感染的危险因素:一项回顾性病例对照研究
Front Microbiol. 2024 Apr 12;15:1355069. doi: 10.3389/fmicb.2024.1355069. eCollection 2024.
8
Development of a risk prediction model for subsequent infection after colonization with carbapenem-resistant Enterobacterales: a retrospective cohort study.耐碳青霉烯类肠杆菌科细菌定植后后续感染风险预测模型的开发:一项回顾性队列研究
Antimicrob Resist Infect Control. 2024 Apr 24;13(1):46. doi: 10.1186/s13756-024-01394-5.
9
Genomic Analysis of Carbapenem-Resistant Hypervirulent in a Chinese Tertiary Hospital.中国一家三级医院耐碳青霉烯类高毒力菌株的基因组分析
Infect Drug Resist. 2023 Sep 27;16:6385-6394. doi: 10.2147/IDR.S425949. eCollection 2023.
10
Carbapenem-Resistant Infection and Its Risk Factors in Older Adult Patients.老年患者耐碳青霉烯类感染及其危险因素。
Clin Interv Aging. 2023 Jul 6;18:1037-1045. doi: 10.2147/CIA.S406214. eCollection 2023.